I now have solid textbook coverage. Let me put together the full analysis.
Hormonal Panel Interpretation
Here is a structured interpretation of these results together, since each value intersects with the others.
LH 18.1 mIU/mL - LH:FSH ratio 2.8:1
The LH:FSH ratio is the most clinically telling finding here. Normally, LH and FSH are roughly equal (ratio ~1:1) in the follicular phase. A ratio above 2:1 - and especially above 2.5-3:1 - is a recognized minor feature of Polycystic Ovary Syndrome (PCOS).
From Harrison's 22E: "Lean oligo-ovulatory patients with PCOS generally have high LH levels in the presence of normal to low levels of FSH and estradiol... a random serum LH/FSH ratio is not included in the diagnostic criteria [but] LH levels are often elevated in polycystic ovary syndrome so that the ratio is increased."
The underlying mechanism: abnormal GnRH pulsatility in PCOS drives preferential LH release. Elevated LH stimulates excess ovarian androgen production (thecal cells), while relatively lower FSH means follicles fail to mature properly, leading to cyst accumulation. Important caveat: this blood draw could also represent a spontaneous LH surge mid-cycle, since normal mid-cycle LH can peak at 25-40+ mIU/mL. The timing of the test relative to the cycle must be known before calling this pathological.
AMH 7.25 ng/mL - High Ovarian Reserve
This is significantly elevated. The typical reference range for reproductive-age women is approximately 1.0-3.5 ng/mL (lab-dependent). Values above 3.5-5.0 ng/mL are considered high, and 7.25 ng/mL is substantially above that.
From Harrison's 22E (2025 Rotterdam criteria update): polycystic ovaries on ultrasound (≥20 antral follicles or ovarian volume ≥10 cm) or elevated AMH is now formally included as one of the three diagnostic criteria. AMH reflects the antral follicle count - a high AMH means many small immature follicles are present, which is the hallmark morphology of PCOS.
High AMH in this context strongly supports a PCOS ovarian pattern - not just "good reserve" in the fertility sense, but excessive follicle accumulation from arrested folliculogenesis. It also correlates with the elevated LH and relatively normal FSH: the follicles stall early without enough FSH stimulation to complete maturation.
Prolactin 29.3 ng/mL - Mild Hyperprolactinemia
Normal range is roughly 5-27 ng/mL. At 29.3 ng/mL, this is mildly elevated, but only slightly above the upper limit.
Key considerations from Berek & Novak's Gynecology:
- Prolactin secretion is pulsatile and diurnal. Levels peak between 5-7 AM and after the onset of sleep. Because this could be an early-morning draw, a mildly elevated value should always be rechecked - ideally mid-morning, fasting, without prior stress, breast stimulation, or recent venipuncture.
- Hypothyroidism and medications (antipsychotics, metoclopramide, domperidone, some antidepressants, opioids, antihypertensives like verapamil) must be ruled out first.
- Macroprolactin (big-big prolactin, biologically inactive) can cause elevated immunoreactive prolactin without clinical consequences - a macroprolactin assay (PEG precipitation) should be requested to exclude this before initiating workup.
- 3-10% of women with PCOS have coexistent modest hyperprolactinemia (Berek & Novak). So this elevation may be secondary to the PCOS-related anovulatory state rather than an independent pituitary lesion.
If the repeat prolactin is persistently elevated (especially above 50-100 ng/mL), pituitary MRI to exclude a prolactinoma becomes necessary. At 29.3 ng/mL, a prolactinoma is unlikely but possible - and hyperprolactinemia itself can mimic PCOS by suppressing GnRH pulsatility, impairing FSH binding, and causing anovulation (Berek & Novak, Ganong's Physiology).
FSH 6.36 mIU/mL and Estradiol 56 pg/mL - Both Normal
FSH is in the normal follicular range (typically 3-10 mIU/mL), confirming no primary ovarian failure (which would show FSH >25 mIU/mL). This rules out premature ovarian insufficiency.
Estradiol at 56 pg/mL is consistent with early-to-mid follicular phase or a low follicular environment. It is not suppressed (which would suggest hypogonadotropic hypogonadism) and not markedly elevated (which might suggest an ovarian granulosa cell tumor or imminent ovulation surge). This is reassuring.
Putting It Together: Clinical Impression
| Feature | Value | Interpretation |
|---|
| LH:FSH ratio | 2.8:1 | Supports PCOS / or mid-cycle LH surge |
| AMH | 7.25 ng/mL (high) | Strong PCOS ovarian pattern; now part of 2023 Rotterdam criteria |
| Prolactin | 29.3 ng/mL (mildly high) | Needs repeat + macroprolactin; common in PCOS; rule out other causes |
| FSH | 6.36 mIU/mL (normal) | No ovarian insufficiency |
| Estradiol | 56 pg/mL (normal) | No hypoestrogenism, no hyperstimulation |
This hormonal picture is most consistent with PCOS, specifically:
- High AMH with elevated LH and normal FSH fits the typical PCOS hormonal signature
- The mildly elevated prolactin is likely a co-phenomenon, not a separate pituitary cause
Recommended Next Steps
- Pelvic ultrasound - antral follicle count and ovarian volume are needed to apply the Rotterdam criteria (≥20 follicles per ovary or volume ≥10 cm³ qualifies)
- Androgens - total testosterone, free testosterone, DHEA-S to confirm biochemical hyperandrogenism (the third Rotterdam criterion)
- Repeat prolactin (mid-morning, fasting) + macroprolactin assay to clarify whether the mild hyperprolactinemia is real and clinically relevant
- TSH - hypothyroidism causes hyperprolactinemia and anovulation; must be excluded
- Fasting glucose / HOMA-IR / lipid panel - if PCOS is confirmed, metabolic screening is standard given the high risk of insulin resistance
- Clinical assessment - menstrual history (cycle regularity, oligomenorrhea), signs of hyperandrogenism (acne, hirsutism using Ferriman-Gallwey score, alopecia), BMI
If prolactin is persistently >50 ng/mL on repeat, add pituitary MRI to exclude a microadenoma (though this value of 29.3 makes a prolactinoma unlikely).
Sources: Harrison's Principles of Internal Medicine 22E (2025); Berek & Novak's Gynecology; Ganong's Review of Medical Physiology 26E; Goldman-Cecil Medicine